These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38748067)

  • 1. Diagnostic value of FDG PET-CT in differentiating lung adenocarcinoma from squamous cell carcinoma.
    Maman A; Çiğdem S; Kaya İ; Demirtaş R; Ceylan O; Özmen S
    EJNMMI Rep; 2024 Jan; 8(1):1. PubMed ID: 38748067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of multiple dual-phase
    Liu X; Zou Q; Sun Y; Liu H; Cailiang G
    Heliyon; 2023 Oct; 9(10):e20180. PubMed ID: 37767476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of diffusion kurtosis imaging and
    Feng P; Shao Z; Dong B; Fang T; Huang Z; Li Z; Fu F; Wu Y; Wei W; Yuan J; Yang Y; Wang Z; Wang M
    Front Oncol; 2022; 12():989131. PubMed ID: 36248958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.
    Zhang F; Wu X; Zhu J; Huang Y; Song X; Jiang L
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3250-3259. PubMed ID: 33630146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of
    Kim E; Wu HG; Keam B; Kim TM; Kim DW; Paeng JC; Kim HJ; Chang JH
    Clin Lung Cancer; 2019 Jan; 20(1):e9-e23. PubMed ID: 30266585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
    Hu WD; Wang HC; Wang YB; Cui LL; Chen XH
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([
    Hughes DJ; Josephides E; O'Shea R; Manickavasagar T; Horst C; Hunter S; Tanière P; Nonaka D; Van Hemelrijck M; Spicer J; Goh V; Bille A; Karapanagiotou E; Cook GJR
    Eur Radiol; 2024 Sep; 34(9):5889-5902. PubMed ID: 38388716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
    Satoh Y; Onishi H; Nambu A; Araki T
    Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value on SUV-derived parameters assessed on
    Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
    BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary tumor standardized uptake value (SUVmax) measured on
    Hui Z; Wei F; Ren H; Xu W; Ren X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma.
    Otani T; Miyake KK; Ishimori T; Kido A; Saga T; Nakamoto Y
    Asia Ocean J Nucl Med Biol; 2023; 11(2):101-110. PubMed ID: 37324226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy.
    Shrestha S; Higuchi T; Shirai K; Tokue A; Shrestha S; Saitoh JI; Hirasawa H; Ohno T; Nakano T; Tsushima Y
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1220-1227. PubMed ID: 31758225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of 18
    Xue J; Zheng J; Guo H; Wang X; Han A
    Mol Clin Oncol; 2015 Jan; 3(1):109-114. PubMed ID: 25469279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between detectable circulating tumor DNA and tumor glucose uptake measured by
    Ottestad AL; Johansen H; Halvorsen TO; Dai HY; Wahl SGF; Emdal EF; Grønberg BH
    BMC Cancer; 2023 Jul; 23(1):646. PubMed ID: 37434111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cigarette smoking on metabolic activity of lung cancer on baseline
    Jiang M; Guo X; Zhang X; Gao Q; Mei W; Zhang J; Zheng J
    PeerJ; 2022; 10():e13352. PubMed ID: 35497180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of volume-based 18F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma.
    Wang D; Li Y; Chen X; Li P
    Medicine (Baltimore); 2021 Sep; 100(35):e27100. PubMed ID: 34477147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
    Aktas GE; Karamustafaoğlu YA; Balta C; Süt N; Sarikaya İ; Sarikaya A
    Nucl Med Commun; 2018 Nov; 39(11):995-1004. PubMed ID: 30188416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer.
    Zuo M; Yao L; Wen L; Shen J; Zhang N; Bai T; Huang Q
    World J Surg Oncol; 2021 Sep; 19(1):262. PubMed ID: 34470640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Metabolic Tumor Volume and Total Lesion Glycolysis to Predict Prognosis in Early-Stage Lung Cancer at Preoperative Staging.
    Karaman E; Goksel S; Tuluce K
    J Coll Physicians Surg Pak; 2022 Jun; 32(6):740-745. PubMed ID: 35686405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.